Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re not investing in healthcare stocks these days, you may be missing out on a huge opportunity. Consider this: We are getting older and living longer as a species. The World Health Organization says that by ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the recent bull run among stocks (especially among riskier, more speculative plays), you may be looking to deploy more capital into the market. Yet while the “hottest” stocks out there today may look like tem...
Finding penny stocks to buy seems simple, but it isn’t as easy as you might think. The main focus is identifying potential catalysts and then making a watch list. One way that some traders begin is by looking for specific attributes. Analyst sentiment is one of these and can be used to fin...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the B. Riley Securities 3 rd Annual Virtual Oncology C...
Clinical-stage biotech Geron Corporation ( NASDAQ: GERN ) announced several recent additions to the company’s senior commercial leadership on Wednesday ahead of the planned launch of its blood cancer therapy imetelstat. Early this month, Geron ( GERN ) said that imetelstati...
Leadership in place for core commercial functions, including in Market Access, Trade & Channel Relations, Commercial Operations, Analytics, Marketing, Sales and Medical Affairs Company continues stage-gated commercial readiness efforts for an anticipated commercial launch of imetelstat in...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the closing of its upsized underwritten public offering of common stock and pre-funded warrants, plus the full exercise of the underwriters’ option to purchase additional shares of common sto...
Summary Primary endpoint of 8-week transfusion independence met in the phase 3 IMerge study; Imetelstat was used as a monotherapy to treat patients with lower-risk myelodysplastic syndrome. Regulatory applications in the U.S. and Europe, of imetelstat for lower-risk myelodysplastic synd...
3 Ways to Start Investing in Penny Stocks Right Now If you’re new to investing, penny stocks can be an attractive option due to their low price point and the potential for large returns. However, it’s important to understand that penny stocks come with a higher level of risk...
Geron ( NASDAQ: GERN ) shares gained 6% premarket on Friday after the biopharmaceutical company priced its $198M upsized offering of 55,876,297 shares and pre-funded warrants to purchase 25M shares. The shares are being offered at $2.45 each, while the pre-funded warrants are ...
News, Short Squeeze, Breakout and More Instantly...
RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible (serum EPO >500 mU/mL) Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart the Company on August 31, 2024, to ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the market opens on Thursday, August 8, 2024 via press release, which will be available on the Company ...